Position Papers

Comprehensive and coordinated response to the Covid-19 pandemic

Our position of the adoption of Omnibus Resolution highlighting the need for global response and effective international cooperation to ensure that no one is left behind in the race against COVID-19.

On behalf of global biopharmaceutical and medical technologies companies, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the International Council of Biotechnology Associations (ICBA), the Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association (DITTA), and the Global Self-Care Federation (GSCF) welcome the adoption of Omnibus Resolution highlighting the need for global response and effective international cooperation to ensure that no one is left behind in the race against COVID-19.

Explore more

Cybersecurity

Clinical Evaluation

Medical Software & Artificial Intelligence

Digital health & cybersecurity

Good refurbishment practice

Environmental policy

Medical device single audit program

Standardisation

Unique Device Identification

Regulated Product Submission

Regulations & Standards

Global Health